<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>Nuclear Dynamics</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0CEC6E19-2999-49FF-95D0-6A682CEB301E"><gtr:id>0CEC6E19-2999-49FF-95D0-6A682CEB301E</gtr:id><gtr:firstName>Wolf</gtr:firstName><gtr:surname>Reik</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A731D157-3123-4B26-9230-43A899BCFF3D"><gtr:id>A731D157-3123-4B26-9230-43A899BCFF3D</gtr:id><gtr:firstName>Gavin</gtr:firstName><gtr:otherNames>Derek</gtr:otherNames><gtr:surname>Kelsey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3BF5E3CF-A378-4AED-A9DE-FC5554476D2D"><gtr:id>3BF5E3CF-A378-4AED-A9DE-FC5554476D2D</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Fraser</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/78B6FA87-3745-4DC0-A3AA-40100F0B4637"><gtr:id>78B6FA87-3745-4DC0-A3AA-40100F0B4637</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:surname>Ferguson-Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/44B55CF6-CDB0-4228-B07D-0EE12D9613F5"><gtr:id>44B55CF6-CDB0-4228-B07D-0EE12D9613F5</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>Varga-Weisz</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801156"><gtr:id>8A74A179-E3FB-4284-B3F6-891C96CA461A</gtr:id><gtr:title>Next Generation Sequencing High Throughput Epigenomics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801156</gtr:grantReference><gtr:abstractText>Recent evidence suggests that an adult individual?s health and susceptibility to common diseases can sometimes be traced back to environmental and nutritional effects experienced by their mothers or grandmothers during pregnancy. The ?experiences? of the foetus during development in its mother?s womb appears to alter the way that an individuals genome is interpreted in later life leading to, in some cases, increase susceptibility to certain diseases. This altered genome interpretation can in some cases be passed passed on to the next generation as well, even in the absence of the original conditions. Though we have the sequence of the entire human genome, we know little about how it works, and how it is interpreted by cells. In this project we will take advantage of recent breakthroughs in DNA sequencing technologies that will permit us to collect hugely increased amounts of data from the genomes of cells before, during and after development. In addition to revealing important information about the workings of the genome these results will provide important insights into the fetal origins of adult disease and potentially lead to new strategies for prevention and new medicines or therapies for treatment of conditions that affect the quality of life.</gtr:abstractText><gtr:technicalSummary>Development is the result of changes in gene expression programmes that give rise to different organs and tissues. With few exceptions, these changes occur without changes to DNA sequence. Changes in epigenetic modifications such as DNA methylation, histone modifications, histone variant deposition and the presence of non-nucleosomal chromatin-associated proteins are strongly linked to the transitions from totipotent to pluripotent stem cells, and precursor cells to fully differentiated somatic cells. Little is known about these interlaced systems work and interact. In this Collaboration Grant we propose to bring together a pre-eminent group of UK scientists working on epigenetics and chromatin during development. Our current funded research programmes are aimed at various and extensive epigenetic analyses of diverse ?developmental? cell-types; including primordial germ cells, developing oocytes, ES cells, blastocysts, TS cells, placenta, fetal liver and adult tissues. Presently these analyses are to be performed with real-time PCR, Sequenom massarray, or microarray based profiling, etc. Each of these techniques is limiting, either in terms of the number of samples or datapoints that can be assessed (PCR and Sequenom) or in the quality and quantitative value of data returned (array techniques). Rather than simply focussing on own little parts of the genome we propose to collaborate in the establishment of a new facility, to take advantage of improvements in DNA sequencing technology to create a database of genome-wide datasets representing an epigenetic time course through development. With the aid of an Illumina Genome Analyzer II (Solexa) massively parallel sequencing system we will generate genome-wide datasets for each experiment, rather than a tiny fragment of the genome. This will allow us to investigate the specific questions outlined in our present research programmes, while at the same time dramatically increasing the output and quality of each experiment. The data from each of the applicants will be deposited in a searchable database curated by the proposed postdoc. The net effect will be to create a programme that is substantially larger, more encompassing and providing much greater insight than the sum of the previous constituent parts. This collaborative database will foster interaction and sharing of expertise between applicants as well as create a shared resource for collaborative publications that would not have been possible without this grant.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>777701</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sanger</gtr:description><gtr:id>1DBF4F47-C093-49B2-B080-9126B87B60A8</gtr:id><gtr:impact>Leading to Associate Faculty Position at Sanger Institute</gtr:impact><gtr:outcomeId>h7x4hqLdG4a-1</gtr:outcomeId><gtr:partnerContribution>Leading to Associate Faculty Position at Sanger Institute</gtr:partnerContribution><gtr:piContribution>Leading to Associate Faculty Position at Sanger Institute</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sanger Single Cell Genomics Centre</gtr:description><gtr:id>E563DA89-9141-4763-B700-F3DD63D8349B</gtr:id><gtr:impact>Genomics, transcriptomics, epigenomics, computational biology</gtr:impact><gtr:outcomeId>CxtgmqJdT8D-1</gtr:outcomeId><gtr:partnerContribution>A number of Sanger and EBI PIs were involved</gtr:partnerContribution><gtr:piContribution>Helped to establish the Single Cell Genomics Centre at Sanger/EBI</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>297C8B38-91B6-436D-9596-F6AB19D4B7CC</gtr:id><gtr:impact>A panel discussion and public debate on epigenetics at the Cheltenham Science Festival 2013

Several enquiries from members of the public who attended</gtr:impact><gtr:outcomeId>GvP2UJZyhwQ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cheltenhamfestivals.com/science/whats-on/2013/flexible-inheritance-epigenetic-effects-on-health/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Summer Exhibition 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EE9CF587-3A2B-4C05-A398-D7E9FFE3A327</gtr:id><gtr:impact>Large public audience attendance over one week of all day exhibition

Much positive feedback from members of the public and scientists attending</gtr:impact><gtr:outcomeId>CdTxhzUByYB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU NoE EpiGeneSys</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>AA541CC3-DDC4-4D7A-9D9E-D25D66D86D30</gtr:id><gtr:outcomeId>F3NZr5N8rfu0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator Award</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>83FA2874-B340-4AE7-89D9-2AA6C4869EA4</gtr:id><gtr:outcomeId>C9XDkmgenwD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EU BLUEPRINT</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>8A25E3F5-8FB2-489A-9C61-E0F71805D1A6</gtr:id><gtr:outcomeId>NNvjBYgu28S</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International Human Epigenome Consortium</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>677A1102-3FFB-477D-A13E-DA76D09C7A9E</gtr:id><gtr:impact>International Human Epigenome Consortium was launched in 2011 with significant input from the MRC community including ourselves.</gtr:impact><gtr:outcomeId>fBCZLq6njja</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Chemical method for sequencing of hydroxymethylation commercialised by Cambridge Epigenetix.</gtr:description><gtr:id>C1156243-77D4-464C-BA26-4C1EE1F1B1CD</gtr:id><gtr:impact>Use in several publications.</gtr:impact><gtr:outcomeId>feX2v2Bvzbe</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Oxidative bisulfite sequencing</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.cambridge-epigenetix.com</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We made an antibody to hydroxymethylcytosine which was commercialised by Diagenode</gtr:description><gtr:id>D8911152-2262-4162-9BA7-E4EF5D963713</gtr:id><gtr:impact>Use in several publications. Development of hydroxymethylcytosine sequencing.</gtr:impact><gtr:outcomeId>sSFc5oLYeVD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Hydroxymethylcytosine antibody</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.diagenode.com/en/index.php</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Whole genome bisulfite sequencing datasets from various mouse tissues</gtr:description><gtr:id>DAAC39DC-9EE6-427F-B182-778B05DD7598</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>ZSpRCtuWau4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Whole genome bisulfite sequencing</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Cambridge Epigenetix</gtr:companyName><gtr:description>Cambridge Epigenetix was spun out of Cambridge University in 2012 based on oxidative bisulfite sequencing IP</gtr:description><gtr:id>701325F7-7EF9-4993-85B6-569DB52ACFC8</gtr:id><gtr:impact>CEG are in the process of developing an oxidative bisulfite sequencing kit</gtr:impact><gtr:outcomeId>PjreuS1ZNLs</gtr:outcomeId><gtr:url>http://www.cegx.co.uk/</gtr:url><gtr:yearCompanyFormed>2012</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>85255F5F-6AE1-441B-8E85-B1E6227ABD22</gtr:id><gtr:title>Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dec6cf848835dc1cbdbd7ef7bee2cd34"><gtr:id>dec6cf848835dc1cbdbd7ef7bee2cd34</gtr:id><gtr:otherNames>Ficz G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>AkrBffT4nGb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>494C274C-B4A1-40AC-9035-0B1166957BBD</gtr:id><gtr:title>FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dec6cf848835dc1cbdbd7ef7bee2cd34"><gtr:id>dec6cf848835dc1cbdbd7ef7bee2cd34</gtr:id><gtr:otherNames>Ficz G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_16416_26_23850245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08AFF6F6-E31A-4FA8-B329-7AA836B62EC9</gtr:id><gtr:title>The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/881eeeb68663bc982713486064538cb7"><gtr:id>881eeeb68663bc982713486064538cb7</gtr:id><gtr:otherNames>Keniry A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>pm_16416_26_22684254</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20B10BFB-336B-4684-8E86-AC1785336A2A</gtr:id><gtr:title>Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e197a00ba92702c3846ba48558e422c4"><gtr:id>e197a00ba92702c3846ba48558e422c4</gtr:id><gtr:otherNames>Raiber EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_16416_26_22902005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2C4483A-4B8E-4654-9B10-085C99C723B3</gtr:id><gtr:title>Methylome analysis using MeDIP-seq with low DNA concentrations.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/652a164f512e49c149aadd0fcf3c285e"><gtr:id>652a164f512e49c149aadd0fcf3c285e</gtr:id><gtr:otherNames>Taiwo O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_16416_26_22402632</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E840F1F1-4BF2-446E-9800-8DBAB81CE65C</gtr:id><gtr:title>Dynamic CpG island methylation landscape in oocytes and preimplantation embryos.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da2da40cd6521591fb9096ba3b2306cd"><gtr:id>da2da40cd6521591fb9096ba3b2306cd</gtr:id><gtr:otherNames>Smallwood SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16416_26_21706000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24B87D36-0A0D-426F-B762-AE67A4E154D3</gtr:id><gtr:title>Dnmt2-dependent methylomes lack defined DNA methylation patterns.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/554150fd606bb627b6f4db6b01d9908d"><gtr:id>554150fd606bb627b6f4db6b01d9908d</gtr:id><gtr:otherNames>Raddatz G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_16416_26_23641003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A3B3417-E7B7-474C-858C-019BF6D5D9CC</gtr:id><gtr:title>Direct sequencing of small genomes on the Pacific Biosciences RS without library preparation.</gtr:title><gtr:parentPublicationTitle>BioTechniques</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc0cffd22d1e32dd0666049823fdbdf0"><gtr:id>cc0cffd22d1e32dd0666049823fdbdf0</gtr:id><gtr:otherNames>Coupland P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0736-6205</gtr:issn><gtr:outcomeId>pm_16416_26_23227987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC57934A-0EBF-4D21-BC1A-5A2D7256F5A9</gtr:id><gtr:title>The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5499f12f4aadb6cb6c1667b0db154b1"><gtr:id>c5499f12f4aadb6cb6c1667b0db154b1</gtr:id><gtr:otherNames>Seisenberger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_16416_26_23219530</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6915A38-30B2-4028-A857-D980A289F8BF</gtr:id><gtr:title>Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4bf6ea085b0e3cb264b6c30c355c548"><gtr:id>c4bf6ea085b0e3cb264b6c30c355c548</gtr:id><gtr:otherNames>Booth MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_16416_26_22539555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFBB3013-AF8F-4F75-A13B-E3BA8FDFA4AE</gtr:id><gtr:title>Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4bf6ea085b0e3cb264b6c30c355c548"><gtr:id>c4bf6ea085b0e3cb264b6c30c355c548</gtr:id><gtr:otherNames>Booth MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_16416_26_24008380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02DBBE3C-39F1-4DFD-BA6F-5428449CE702</gtr:id><gtr:title>Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffac7df9eb1678b309e176690c37081e"><gtr:id>ffac7df9eb1678b309e176690c37081e</gtr:id><gtr:otherNames>Fellows R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a8adb1b40bd19.05327565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7622A4BC-D245-42A0-8B10-D0BB3FA7A612</gtr:id><gtr:title>BLUEPRINT to decode the epigenetic signature written in blood.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41ee338773829acb3c4e72f873e16db3"><gtr:id>41ee338773829acb3c4e72f873e16db3</gtr:id><gtr:otherNames>Adams D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_16416_26_22398613</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801156</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>